Iravani Kamyar, Doostkam Aida, Roozbeh Jamshid, Malekmakan Leila, Kasaee Seyed Reza, Soltaniesmaeili Amir
Department of Otolaryngology, Otolaryngology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Nephro-Urology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Caspian J Intern Med. 2025 Mar 21;16(2):289-296. doi: 10.22088/cjim.16.2.289. eCollection 2025 Spring.
Olfactory changes connection to deteriorated quality of life in chronic kidney disease cases (CKD) and diabetes mellitus (DM). The nutritional status is altered in CKD and DM and it closely interconnected with olfactory function. We aimed to study the olfactory dysfunction in these populations.
We conducted a cross-sectional research on CKD and DM cases aged 20-50 (27 healthy controls, 77 CKD patients, and 36 DM patients). We used the Iran Smell Identification Test (Iran-SIT) version of the University of Pennsylvania Smell Identification Test (UPSIT) to evaluate the olfactory function. The significant level was set as <0.05.
Our 140 cases included 51.4% of men (mean age of 46.7±10.6 years). The total score of the Iran-SIT test indicated that olfactory impairment in the CKD was higher (16.2±4.2) than in the DM (18.8±2.1) and control groups (20.4±1.2) (P=0.001). It was determined that 54.5% of CKD patients and 38.9% of the DM group had olfactory dysfunction compared to 7.4% of the controls (P=0.001). Multiple regression analysis indicated that being men and low-density lipoprotein cholesterol (LDL-C) were related to olfactory dysfunction in the total population (OR: 4.55, P=0.037, and OR: 0.94, P=0.037). Still, it was only associated with LDL-C in the CKD group (OR: 0.93, P=0.013).
Based on the findings of this study, CKD and DM patients had a higher prevalence of olfactory dysfunction than the controls, which could be associated with some preventive nutritional factors. This information may help perform a screening program and early intervention on olfactory dysfunction in these systematic diseases.
嗅觉变化与慢性肾脏病(CKD)和糖尿病(DM)患者生活质量下降有关。CKD和DM患者的营养状况会发生改变,且与嗅觉功能密切相关。我们旨在研究这些人群中的嗅觉功能障碍。
我们对20至50岁的CKD和DM患者进行了一项横断面研究(27名健康对照者、77名CKD患者和36名DM患者)。我们使用宾夕法尼亚大学嗅觉识别测试(UPSIT)的伊朗嗅觉识别测试(Iran-SIT)版本来评估嗅觉功能。显著性水平设定为<0.05。
我们的140例患者中男性占51.4%(平均年龄46.7±10.6岁)。Iran-SIT测试的总分表明,CKD患者的嗅觉损害程度(16.2±4.2)高于DM患者(18.8±2.1)和对照组(20.4±1.2)(P=0.001)。与对照组的7.4%相比,54.5%的CKD患者和38.9%的DM组存在嗅觉功能障碍(P=0.001)。多元回归分析表明,男性和低密度脂蛋白胆固醇(LDL-C)与总体人群的嗅觉功能障碍有关(OR:4.55,P=0.037;OR:0.94,P=0.037)。然而,在CKD组中仅与LDL-C相关(OR:0.93,P=0.013)。
基于本研究结果,CKD和DM患者嗅觉功能障碍的患病率高于对照组,这可能与一些预防性营养因素有关。这些信息可能有助于对这些系统性疾病中的嗅觉功能障碍进行筛查和早期干预。